Irrimax Corporation is a wholly owned subsidiary of Innovation Technologies, Inc. Innovation Technologies holds the rights to US and worldwide patents that provide broad protection for the use of low concentration CHG (less than 1%) technology. Irrimax Corporation, as the operating company, develops, manufactures and markets Irrisept, a wound debridement and cleansing system that contains 0.05% Chlorhexidine Gluconate (CHG) in sterile water for irrigation.

If you are interested in learning about investment opportunities, or are a current investor, please contact: or call +1 770.807.3355.

Print Friendly, PDF & Email